Windlas Biotech Ltd
NSE:WINDLAS
Windlas Biotech Ltd
NSE:WINDLAS
Price:
788
INR
0.05%
Market Cap:
₹16.6B
Income Statement
Earnings Waterfall
Windlas Biotech Ltd
Windlas Biotech Ltd
Income Statement
Windlas Biotech Ltd
Windlas Biotech Ltd
Currency: INR
| Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||
| Interest Expense |
0
|
0
|
13
|
0
|
0
|
0
|
8
|
0
|
0
|
0
|
11
|
0
|
0
|
0
|
44
|
0
|
0
|
|
| Revenue |
3 330
N/A
|
4 506
+35%
|
4 659
+3%
|
4 749
+2%
|
4 924
+4%
|
4 945
+0%
|
5 131
+4%
|
5 379
+5%
|
5 579
+4%
|
6 004
+8%
|
6 310
+5%
|
6 613
+5%
|
6 957
+5%
|
7 285
+5%
|
7 599
+4%
|
7 948
+5%
|
8 302
+4%
|
|
| Gross Profit | ||||||||||||||||||
| Cost of Revenue |
(2 174)
|
(2 944)
|
(3 138)
|
(3 080)
|
(3 173)
|
(3 161)
|
(3 384)
|
(3 405)
|
(3 520)
|
(3 779)
|
(4 123)
|
(4 141)
|
(4 346)
|
(4 538)
|
(4 935)
|
(4 922)
|
(5 127)
|
|
| Gross Profit |
1 156
N/A
|
1 562
+35%
|
1 521
-3%
|
1 670
+10%
|
1 751
+5%
|
1 785
+2%
|
1 747
-2%
|
1 974
+13%
|
2 059
+4%
|
2 225
+8%
|
2 186
-2%
|
2 472
+13%
|
2 610
+6%
|
2 746
+5%
|
2 664
-3%
|
3 026
+14%
|
3 175
+5%
|
|
| Operating Income | ||||||||||||||||||
| Operating Expenses |
(884)
|
(1 191)
|
(1 118)
|
(1 250)
|
(1 301)
|
(1 325)
|
(1 269)
|
(1 466)
|
(1 529)
|
(1 634)
|
(1 539)
|
(1 818)
|
(1 944)
|
(2 073)
|
(1 999)
|
(2 321)
|
(2 426)
|
|
| Selling, General & Administrative |
(477)
|
(634)
|
(911)
|
(639)
|
(666)
|
(687)
|
(1 037)
|
(743)
|
(778)
|
(828)
|
(1 300)
|
(947)
|
(1 044)
|
(1 138)
|
(1 632)
|
(1 273)
|
(1 328)
|
|
| Research & Development |
0
|
0
|
(65)
|
0
|
0
|
0
|
(89)
|
0
|
0
|
0
|
(79)
|
0
|
0
|
0
|
(63)
|
0
|
0
|
|
| Depreciation & Amortization |
(95)
|
(126)
|
(122)
|
(119)
|
(117)
|
(117)
|
(124)
|
(128)
|
(132)
|
(135)
|
(134)
|
(165)
|
(196)
|
(232)
|
(280)
|
(292)
|
(303)
|
|
| Other Operating Expenses |
(312)
|
(432)
|
(21)
|
(493)
|
(518)
|
(522)
|
(19)
|
(596)
|
(618)
|
(670)
|
(26)
|
(706)
|
(704)
|
(702)
|
(24)
|
(756)
|
(795)
|
|
| Operating Income |
272
N/A
|
371
+36%
|
403
+9%
|
420
+4%
|
450
+7%
|
459
+2%
|
479
+4%
|
508
+6%
|
530
+4%
|
591
+12%
|
647
+9%
|
654
+1%
|
666
+2%
|
674
+1%
|
665
-1%
|
705
+6%
|
749
+6%
|
|
| Pre-Tax Income | ||||||||||||||||||
| Interest Income Expense |
(13)
|
(15)
|
53
|
(13)
|
(10)
|
(9)
|
79
|
(7)
|
(8)
|
(10)
|
120
|
(14)
|
(22)
|
(33)
|
127
|
(49)
|
(49)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
9
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
27
|
45
|
(1)
|
89
|
103
|
106
|
4
|
97
|
104
|
114
|
4
|
150
|
166
|
175
|
5
|
191
|
179
|
|
| Pre-Tax Income |
287
N/A
|
401
+40%
|
456
+14%
|
495
+9%
|
543
+10%
|
557
+2%
|
570
+2%
|
598
+5%
|
625
+4%
|
695
+11%
|
771
+11%
|
791
+3%
|
810
+2%
|
816
+1%
|
798
-2%
|
847
+6%
|
880
+4%
|
|
| Net Income | ||||||||||||||||||
| Tax Provision |
(78)
|
(109)
|
(75)
|
(83)
|
(92)
|
(97)
|
(144)
|
(149)
|
(158)
|
(169)
|
(189)
|
(195)
|
(198)
|
(199)
|
(188)
|
(195)
|
(207)
|
|
| Income from Continuing Operations |
209
|
292
|
381
|
412
|
451
|
460
|
426
|
449
|
467
|
526
|
582
|
596
|
612
|
617
|
610
|
652
|
673
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
209
N/A
|
292
+40%
|
381
+30%
|
412
+8%
|
451
+9%
|
460
+2%
|
426
-7%
|
449
+5%
|
467
+4%
|
526
+13%
|
582
+11%
|
596
+2%
|
612
+3%
|
617
+1%
|
610
-1%
|
652
+7%
|
673
+3%
|
|
| EPS (Diluted) |
10.34
N/A
|
13.39
+29%
|
18.58
+39%
|
18.89
+2%
|
20.68
+9%
|
21.18
+2%
|
19.7
-7%
|
21.54
+9%
|
22.48
+4%
|
25.31
+13%
|
27.88
+10%
|
28.47
+2%
|
29.05
+2%
|
29.23
+1%
|
28.87
-1%
|
30.77
+7%
|
31.79
+3%
|
|
Switch to:
Switch to:
See Also
Discover More
